John Ransom Analyst PerformanceManaging Director, Director of Healthcare Research Alternate Site Healthcare Providers/Healthcare In at Raymond James FinancialJohn Ransom is a stock analyst at Raymond James Financial focused in the medical sector, covering 16 publicly traded companies. Over the past year, John Ransom has issued 15 stock ratings, including strong buy and buy recommendations. While full access to John Ransom's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights John Ransom's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings31 Last 11 YearsBuy Recommendations96.67% 29 Buy RatingsCompanies Covered16 Unique Companies Ratings Distribution30RatingsDistribution of strong buy, buy, hold, and sell ratings by John Ransom.RatingPercentageCount Strong Buy33.3%10 ratings Buy63.3%19 ratings Hold0.0%0 ratings Sell3.3%1 ratingsOut of 30 total stock ratings issued by John Ransom at Raymond James Financial, the majority (63.3%) have been Buy recommendations, followed by 33.3% Strong Buy and 3.3% Sell.Best & Worst CallsBest Call0000.0%PHRApr 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%CYHAug 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE62.5% of companies on NYSE10 companiesNASDAQ37.5% of companies on NASDAQ6 companiesJohn Ransom, an analyst at Raymond James Financial, currently covers 16 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical14 companies87.5%Services1 company6.3%Consumer Staples1 company6.3%John Ransom of Raymond James Financial specializes in stock coverage within the Medical sector, with additional focus on Services and Consumer Staples companies.Coverage IndustriesIndustryPercentageMED - OUTP/HM CRE4 companies25.0%MED - HOSPITALS4 companies25.0%MED - HMO2 companies12.5%MEDICAL INFO SYS2 companies12.5%MED - DRUGS1 company6.3%SERVICES – HEALTH1 company6.3%FUNERAL SVS&REL1 company6.3%MEDICAL SERVICES1 company6.3% About John RansomJohn Ransom has more than 35 years of experience in healthcare finance. He spent co-founded the healthcare finance group at First Union (now Wells Fargo) in 1987 before joining Raymond James in 1996 as a healthcare services analyst. In addition to serving as managing director of the healthcare group and a member of the Raymond James benefit committee, Mr. Ransom covers a diverse array of sectors, including managed care, healthcare providers and tech-enabled healthcare solutions. He earned his bachelor’s degree from Presbyterian College and his MBA from the University of Georgia.Follow on LinkedIn John Ransom's Ratings History at Raymond James Financial Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsUNHUnitedHealth Group4/1/2026Upgrade$270.24$330.00Outperform$0.0000.00% ROIGRDNGuardian Pharmacy Services3/12/2026Reiterated Rating$33.03$40.00Outperform$0.0000.00% ROILMRILumexa Imaging2/9/2026Upgrade$10.80$23.00Strong-Buy$0.0000.00% ROIRDNTRadNet12/18/2025Reiterated Rating$71.24Strong-Buy$0.0000.00% ROIAVAHAveanna Healthcare12/5/2025Reiterated Rating$9.14$13.00Outperform$0.0000.00% ROIRDNTRadNet11/14/2025Reiterated Rating$73.46$95.00Strong-Buy$0.0000.00% ROIUHSUniversal Health Services11/3/2025Set Price Target$217.19$270.00Outperform$0.0000.00% ROIUHSUniversal Health Services11/3/2025Upgrade$220.53$270.00Outperform$0.0000.00% ROIACHCAcadia Healthcare10/3/2025Boost Price Target$26.62$30.00Outperform$0.0000.00% ROIACHCAcadia Healthcare8/14/2025Reiterated Rating$20.77$26.00Outperform$0.0000.00% ROIRDNTRadNet8/13/2025Reiterated Rating$63.60$75.00Strong-Buy$0.0000.00% ROIAVAHAveanna Healthcare8/11/2025Upgrade$6.14$9.00Outperform$0.0000.00% ROISCIService Corporation International8/4/2025Reiterated Rating$79.03$90.00Outperform$0.0000.00% ROITHCTenet Healthcare7/23/2025Reiterated Rating$158.26$200.00Outperform$0.0000.00% ROIGRDNGuardian Pharmacy Services5/14/2025Set Price Target$24.62$28.00Outperform$0.0000.00% ROIUNHUnitedHealth Group4/21/2025Reiterated Rating$434.34$540.00Strong-Buy$000.0000.00% ROIRDNTRadNet3/5/2025Upgrade$51.83$65.00Strong-Buy$00.0000.00% ROICICigna Group1/31/2025Reiterated Rating$296.88$360.00Strong-Buy$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialTD CowenPiper SandlerRaymond James FinancialStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
